Comparison of olfactory and cognitive measures to neuroimaging biomarkers in the prediction of cognitive decline and dementia in the MCSA cohort
Davangere Devanand, Seonjoo Lee, David S Knopman, Maria Vassilaki, Jose A Luchsinger, Jeffrey N Motter · 2025
Read Comparison of olfactory and cognitive measures to neuroimaging biomarkers in the prediction of cognitive decline and dementia in the MCSA cohort by Davangere Devanand, Seonjoo Lee, David S Knopman, Maria Vassilaki, Jose A Luchsinger, Jeffrey N Motter (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715300.txt.
Description
Davangere Devanand and five co-authors set cheap bedside tests against costly brain scans as warners of decline. One test asks a person to name twelve smells, and the next is a short test of memory and facts. The scans map amyloid build-up and brain fuel use. The Mayo Clinic Study of Aging gave the team a town-based group to work with.
At the start, six hundred forty-seven adults aged fifty-five and up took all the tests. Over about eight years, one hundred two slid to a worse thought state, and thirty-four reached dementia. The amyloid scan warned best of all. Yet the smell test and the short thought test warned nearly as well on their own. Used as a pair, the two cheap tests made a strong, low-cost way to flag who needs close watch.
Catalog record
| CREATOR | Davangere Devanand, Seonjoo Lee, David S Knopman, Maria Vassilaki, Jose A Luchsinger, Jeffrey N Motter |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |